Single-cell RNA sequencing revealed the roles of macromolecule epidermal growth factor receptor (EGFR) in the hybrid sterility of hermaphroditic Argopecten scallops

被引:0
|
作者
Yu, Tieying [1 ,4 ]
Wang, Chunde [1 ,3 ]
Fan, Jiawei [1 ,4 ]
Chen, Rongjie [5 ]
Liu, Guilong [6 ]
Xu, Xin [6 ]
Ning, Junhao [1 ]
Lu, Xia [2 ]
机构
[1] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Res & Dev Ctr Efficient Utilizat Coastal Bioresour, Yantai 264003, Shandong, Peoples R China
[2] Yantai Univ, Sch Ocean, Yantai 264005, Shandong, Peoples R China
[3] Qingdao Agr Univ, Coll Marine Sci & Engn, Qingdao 266109, Shandong, Peoples R China
[4] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[5] Laizhou Marine Dev & Fishery Serv Ctr, Laizhou 261400, Peoples R China
[6] Yantai Spring Sea AquaSeed Ltd, Yantai 264006, Peoples R China
基金
中国国家自然科学基金;
关键词
Epidermal growth factor receptor; Hybrid sterility; Argopecten scallops; ATP; ROS; BAY SCALLOP; ACTIVATION; DIFFERENTIATION; EXPRESSION; EGGSHELL; EMBRYOS; GENE;
D O I
10.1016/j.ijbiomac.2024.136062
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The macromolecule epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein that belongs to the protein kinase superfamily, which plays versatile functions in cell proliferation, development and fertility regulation. Almost all F1 hybrids obtained from the hermaphroditic bay scallops and Peruvian scallops exhibit infertility, and the genetic mechanism remains unclear. In this study, the comprehensive scRNA-seq was first conducted in the gonads of hybrid scallops, deducing the developmental sequence of germ cells and identifying the critical regulators in hybrid sterility: epidermal growth factor receptor. During the development from oogenesis phase germ cells to oocytes, the expression of the EGFR gene gradually decreased in sterile hybrids but increased in fertile hybrids. The significantly lower EGFR expression and ATP content, but higher ROS production rate was detected in the gonad of sterile hybrids than that in fertile hybrids, which might cause slow development of oocytes, stagnation of cell cycle, insufficient energy supply, high level of apoptosis and final sterility. Specific knock-down of EGFR gene led to decreased ATP content, increased ROS production rate, and inhibited oocyte maturation and gonadal development. These findings provide new insights into the roles of EGFR in hybrid infertility of bivalves and the healthy development of scallop breeding.
引用
收藏
页数:13
相关论文
共 34 条
  • [21] Single-Cell Analysis Reveals Adipose Cancer-Associated Fibroblasts Linked to Trastuzumab Resistance in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Zhang, Siming
    Huang, Xiaojia
    Zhu, Wenbiao
    Liu, Yumei
    Qiu, Ni
    Cai, Zheyou
    Xu, Tai
    Wu, Yuan
    Fan, Yuanlin
    Qiu, Dongqin
    Zhu, Junqiang
    Li, Hongsheng
    SCIENCE OF ADVANCED MATERIALS, 2023, 15 (10) : 1385 - 1393
  • [22] Non-Small Cell Lung Cancer (NSCLC) harboring Epidermal Growth Factor Receptor mutations (EGFR-m) and breast cancer (BC): A retrospective analysis of a single institution.
    Moran, Teresa
    Quiroga, Vanesa
    Carcereny Costa, Enric
    Cirauqui, Beatriz
    Margeli, Mireia
    VilA Martinez, Laia
    Gil Moreno, Maria de los Llanos Gil
    Indacochea, Alberto
    Cuadra Urteaga, Jose Luis
    Queralt, Cristina
    de Aguirre, Itziar
    Luis Ramirez, Jose
    Castella, Eva
    Lopez, Yessica
    Luis Mate, Jose
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] Effects of DMSO, glycerol, betaine and their combinations in detecting single nucleotide polymorphisms of epidermal growth factor receptor (EGFR) gene promoter sequence in non-small-cell lung cancer (NSCLC) patients
    Jurisic, Vladimir
    Obradovic, Jasmina
    Tosic, Natasa
    Pavlovic, Sonja
    Kulic, Milan
    Djordjevic, Natasa
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2016, 128 : 275 - 279
  • [24] PHASE I SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR PF-06747775 IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS.
    Masters, J. C.
    Zientek, M. A.
    Kirkovsky, L.
    Goldberg, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S81 - S82
  • [25] PHASE I SINGLE ANDMULTIPLE-DOSE PHARMACOKINETICS OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR PF-06747775 IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS.
    Masters, J. C.
    Zientek, M. A.
    Kirkovsky, L.
    Goldberg, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S9 - S9
  • [26] Patients harboring epidermal growth factor receptor (EGFR) double mutations had a lower objective response rate than those with a single mutation in non-small cell lung cancer when treated with EGFR-tyrosine kinase inhibitors
    Wei, Zhigang
    An, Tongtong
    Wang, Zhijie
    Chen, Keneng
    Bai, Hua
    Zhu, Guangying
    Duan, Jianchun
    Wu, Meina
    Yang, Lu
    Zhuo, Minglei
    Wang, Yuyan
    Liu, Xuyi
    Wang, Jie
    THORACIC CANCER, 2014, 5 (02) : 126 - 132
  • [27] Real-world mutational profiling of Chinese non-small cell lung cancer patients with epidermal growth factor receptor (EGFR) uncommon mutations acquired resistant to icotinib using next generation sequencing: A multicenter study.
    Wang, Wen Xian
    Xu, Chunwei
    Lei, Lei
    Zhu, You-cai
    Li, Jinluan
    Chen, Huafei
    Fang, Yong
    Wang, Hong
    Zhuang, Wu
    Fang, Meiyu
    Zhang, Yinbin
    Wang, Liping
    Zhang, Huibao
    Zhou, Ying
    Zheng, Yu
    Hu, Xugang
    Jiang, Weiping
    Chen, Gang
    Lv, Tangfeng
    Song, Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION ANALYSES IN TUMOR AND PLASMA SAMPLES FROM A PHASE IV, SINGLE-ARM STUDY OF FIRST-LINE GEFITINIB IN CAUCASIAN PATIENTS WITH EGFR MUTATION-POSITIVE, ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
    Douillard, Jean-Yves
    Ostoros, Gyula
    Cobo, Manuel
    Ciuleanu, Tudor
    Mccormack, Rose
    Webster, Alan
    Milenkova, Tsveta
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1194 - S1195
  • [29] PHASE IV, SINGLE-ARM STUDY OF FIRST-LINE GEFITINIB IN CAUCASIAN PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION-POSITIVE, ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC): POST-HOC EXPLORATORY ANALYSES OF EGFR MUTATIONS IN PLASMA-DERIVED CFDNA SAMPLES
    Douillard, Jean-Yves
    Ostoros, Gyula
    Cobo, Manuel
    Ciuleanu, Tudor
    Mccormack, Rose
    Webster, Alan
    Milenkova, Tsveta
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S899 - S900
  • [30] First-line gefitinib in Caucasian patients (pts) with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer (NSCLC): Results from a multinational, prospective,,open-label, single-arm Phase IV study
    Ostoros, G.
    Cobo, M.
    Ciuleanu, T.
    McCormack, R.
    Webster, A.
    Milenkova, T.
    Douillard, J. Y.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S820 - S820